← All organizations

Resistentia Pharmaceuticals AB

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Feb 1, 2007

Defunct as of Feb 1, 2017

Timeline

1990s

Jun 1, 1998
Resistentia Pharmaceuticals AB— Founded

2010s

Feb 1, 2017
Resistentia Pharmaceuticals AB— Defunct

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

rp 01

Indications

Studied for

Hypersensitivity

Recent trials (2)

NCT00439621Study directorPhase 2Feb 1, 2007
NCT00439621Lead sponsorPhase 2Feb 1, 2007

Details

Founded: Uppsala, SE Jun 1, 1998
Last known activity: Feb 1, 2007

Notes

No evidence it is extant